摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3R)-N-[(2R)-5-amino-1-hydroxypentan-2-yl]-3-butoxybutanamide

中文名称
——
中文别名
——
英文名称
(3R)-N-[(2R)-5-amino-1-hydroxypentan-2-yl]-3-butoxybutanamide
英文别名
——
(3R)-N-[(2R)-5-amino-1-hydroxypentan-2-yl]-3-butoxybutanamide化学式
CAS
——
化学式
C13H28N2O3
mdl
——
分子量
260.37
InChiKey
HHBSQVMPVCLKMB-VXGBXAGGSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.2
  • 重原子数:
    18
  • 可旋转键数:
    11
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.92
  • 拓扑面积:
    84.6
  • 氢给体数:
    3
  • 氢受体数:
    4

文献信息

  • IMMUNOMODULATORY COMPOUNDS AND TREATMENT OF DISEASES RELATED TO AN OVERPRODUCTION OF INFLAMMATORY CYTOKINES
    申请人:Bauer Jacques
    公开号:US20090054378A1
    公开(公告)日:2009-02-26
    Method of using immunomodulatory compounds for treating diseases related to an overproduction of inflammatory cytokines, including diseases selected from asthma, atopic dermatitis, allergic rhinitis, prostatitis, inflammatory bowel disease, diabetes, and rhumatoid arthritis, the compounds being of general formula (I): wherein: m and n, independently from each other, are an integer ranging from 1 to 4, X and Y represent —COOH, —O—P(O)(OH) 2 , —O—SO 2 (OH), —NH 2 , —OH, —CONH(CH 2 ) n1 —NH 2 , —CO—NH—CH(COOH)—(CH 2 ) n1 —COOH, —CO—NH—CH(COOH)—(CH 2 ) n1 —NH 2 , —O—CO—(CH 2 ) n1 —NH 2 , —O—CO—(CH 2 ) n1 —CHOH—CH 2 OH, —O—CO—(CH 2 ) n1 —OH, O—CO—(CH 2 ) n1 —COOH, —O—CO—(CH 2 ) n1 —CHO, —O—CO—(CH 2 ) n1 —NH—CO—(CH 2 ) n2 —COOH, R 1 and R 2 each designate an acyl group derived from a saturated or unsaturated, straight- or branched-chain carboxylic acid having from 2 to 18 carbon atoms, which is unsubstituted or bears one to three substituents selected among hydroxyl, dihydroxyphosphoryloxy, alkyl of 2 to 10 carbon atoms, alkoxy of 2 to 10 carbon atoms, acyloxy of 2 to 18 carbon atoms in the acyl moiety, amino, acylamino.
    使用免疫调节化合物治疗与炎症细胞因子过度产生相关的疾病的方法,包括从哮喘、特应性皮炎、过敏性鼻炎、前列腺炎、炎症性肠病、糖尿病和类风湿关节炎中选择的疾病,所述化合物具有通式(I):其中:m和n分别独立于彼此,为1至4之间的整数,X和Y代表—COOH,—O—P(O)(OH)2,—O—SO2(OH),—NH2,—OH,—CONH(CH2)n1—NH2,—CO—NH—CH(COOH)—( )n1—COOH,—CO—NH—CH(COOH)—( )n1—NH2,—O—CO—( )n1—NH2,—O—CO—( )n1—CHOH— OH,—O—CO—( )n1—OH,O—CO—( )n1—COOH,—O—CO—( )n1—CHO,—O—CO—( )n1—NH—CO—( )n2—COOH,R1和R2各自指代从饱和或不饱和、直链或支链的具有2至18个碳原子的羧酸衍生的酰基,该酰基未取代或带有1到3个在2到10个碳原子的烷基、2到10个碳原子的烷氧基、2到18个碳原子的酰氧基在酰基部分、基、酰基中选择的取代基。
  • US7915240B2
    申请人:——
    公开号:US7915240B2
    公开(公告)日:2011-03-29
查看更多